Federation des caisses Desjardins du Quebec’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,259
| Closed | -$5.87K | – | 3068 |
|
|
2025
Q4 | $5.87K | Buy |
2,259
+2,000
| +772% | +$4.03K | ﹤0.01% | 2412 |
|
|
2025
Q3 | $456 | Sell |
259
-600
| -70% | -$961 | ﹤0.01% | 2736 |
|
|
2025
Q2 | $1.19K | Hold |
859
| – | – | ﹤0.01% | 2482 |
|
|
2025
Q1 | $847 | Sell |
859
-250
| -23% | -$301 | ﹤0.01% | 2434 |
|
|
2024
Q4 | $1.45K | Hold |
1,109
| – | – | ﹤0.01% | 2271 |
|
|
2024
Q3 | $3.81K | Hold |
1,109
| – | – | ﹤0.01% | 2134 |
|
|
2024
Q2 | $3.66K | Hold |
1,109
| – | – | ﹤0.01% | 2019 |
|
|
2024
Q1 | $5.22K | Hold |
1,109
| – | – | ﹤0.01% | 1954 |
|
|
2023
Q4 | $8.1K | Sell |
1,109
-50
| -4% | -$280 | ﹤0.01% | 1797 |
|
|
2023
Q3 | $14K | Buy |
1,159
+50
| +5% | +$516 | ﹤0.01% | 1669 |
|
|
2023
Q2 | $11.7K | Hold |
1,109
| – | – | ﹤0.01% | 1711 |
|
|
2023
Q1 | $10.9K | Hold |
1,109
| – | – | ﹤0.01% | 1738 |
|
|
2022
Q4 | $16.3K | Hold |
1,109
| – | – | ﹤0.01% | 1743 |
|
|
2022
Q3 | $13.5K | Hold |
1,109
| – | – | ﹤0.01% | 1842 |
|
|
2022
Q2 | $15.5K | Hold |
1,109
| – | – | ﹤0.01% | 1842 |
|
|
2022
Q1 | $15.8K | Hold |
1,109
| – | – | ﹤0.01% | 1893 |
|
|
2021
Q4 | $23.4K | Hold |
1,109
| – | – | ﹤0.01% | 1788 |
|
|
2021
Q3 | $29.1K | Hold |
1,109
| – | – | ﹤0.01% | 1745 |
|
|
2021
Q2 | $34.6K | Buy |
1,109
+415
| +60% | +$13.6K | ﹤0.01% | 1706 |
|
|
2021
Q1 | $21.3K | Buy |
694
+94
| +16% | +$3.19K | ﹤0.01% | 1789 |
|
|
2020
Q4 | $20.6K | Hold |
600
| – | – | ﹤0.01% | 1738 |
|
|
2020
Q3 | $18.5K | Buy |
+600
| New | +$15.9K | ﹤0.01% | 1518 |
|
Federation des caisses Desjardins du Quebec's RPTX Position: Q1 2026 in Review
Federation des caisses Desjardins du Quebec sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 2,259 shares — an estimated $5.87K sold.
Federation des caisses Desjardins du Quebec first reported a position in RPTX in Q3 2020 and held it in 22 quarters. The position peaked at $34.6K in Q2 2021. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.
- Federation des caisses Desjardins du Quebec reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 2,259 Repare Therapeutics shares in Q1 2026, an estimated $5.87K.
- Federation des caisses Desjardins du Quebec first reported a position in Repare Therapeutics in Q3 2020 and held it in 22 quarters.
- Federation des caisses Desjardins du Quebec's Repare Therapeutics position peaked at $34.6K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.